tiprankstipranks
Trending News
More News >
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
Advertisement

CytoMed Therapeutics Limited (GDTC) Ratios

Compare
10 Followers

CytoMed Therapeutics Limited Ratios

GDTC's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, GDTC's free cash flow was decreased by $ and operating cash flow was $-20.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.25 14.08 0.60 1.12 0.54
Quick Ratio
7.25 14.08 0.46 0.97 0.45
Cash Ratio
5.68 12.55 0.38 0.86 0.32
Solvency Ratio
-3.71 -2.72 -0.61 -0.50 -0.49
Operating Cash Flow Ratio
-4.40 -3.63 -0.34 -0.58 -0.31
Short-Term Operating Cash Flow Coverage
-79.23 -76.68 -0.37 -0.64 -0.36
Net Current Asset Value
$ 3.65M$ 8.97M$ -1.59M$ -154.68K$ -1.41M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.04 0.81 0.54 0.78
Debt-to-Equity Ratio
0.07 0.05 7.19 1.26 6.26
Debt-to-Capital Ratio
0.07 0.05 0.88 0.56 0.86
Long-Term Debt-to-Capital Ratio
0.06 0.05 0.44 0.17 0.55
Financial Leverage Ratio
1.12 1.46 8.91 2.35 8.02
Debt Service Coverage Ratio
-65.63 -86.61 -0.39 -0.55 -0.44
Interest Coverage Ratio
-161.09 0.00 -15.08 -16.46 -11.91
Debt to Market Cap
0.02 <0.01 0.10 0.09 0.09
Interest Debt Per Share
0.04 0.04 0.41 0.36 0.40
Net Debt to EBITDA
0.80 2.91 -1.77 -0.46 -2.17
Profitability Margins
Gross Profit Margin
19.16%73.34%97.60%96.92%92.22%
EBIT Margin
-1790.09%-1037.76%-1077.55%-2030.86%-3838.93%
EBITDA Margin
-1688.39%-1011.10%-410.85%-1412.07%-1620.57%
Operating Profit Margin
-1682.50%-1002.20%-518.81%-1701.84%-2112.48%
Pretax Profit Margin
-1385.42%-1077.75%-860.05%-1822.31%-3266.03%
Net Profit Margin
-1379.08%-1077.85%-887.02%-1822.31%-3266.03%
Continuous Operations Profit Margin
-1706.26%-1077.92%-1194.06%-2464.45%-4323.43%
Net Income Per EBT
99.54%100.01%103.14%100.00%100.00%
EBT Per EBIT
82.34%107.54%165.77%107.08%154.61%
Return on Assets (ROA)
-41.15%-25.32%-61.75%-34.11%-50.91%
Return on Equity (ROE)
-40.36%-36.88%-549.93%-80.03%-408.06%
Return on Capital Employed (ROCE)
-54.70%-24.99%-177.81%-61.58%-115.25%
Return on Invested Capital (ROIC)
-54.43%-24.91%-39.29%-31.95%-38.41%
Return on Tangible Assets
-41.68%-25.35%-61.98%-34.29%-51.52%
Earnings Yield
-12.90%-6.01%-7.57%-5.53%-6.22%
Efficiency Ratios
Receivables Turnover
1.98 1.42 6.32 21.52 4.95
Payables Turnover
4.61 3.15 0.60 0.08 0.24
Inventory Turnover
0.00 0.00 0.02 <0.01 0.02
Fixed Asset Turnover
0.09 0.19 0.15 0.05 0.03
Asset Turnover
0.03 0.02 0.07 0.02 0.02
Working Capital Turnover Ratio
0.05 0.07 -0.55 -0.24 -0.11
Cash Conversion Cycle
105.06 141.21 23.56K 40.16K 17.55K
Days of Sales Outstanding
184.28 257.20 57.75 16.96 73.79
Days of Inventory Outstanding
0.00 0.00 24.12K 44.96K 18.96K
Days of Payables Outstanding
79.22 115.99 612.30 4.82K 1.49K
Operating Cycle
184.28 257.20 24.18K 44.97K 19.04K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.23 -0.24 -0.13 -0.18 -0.11
Free Cash Flow Per Share
-0.35 -0.25 -0.18 -0.24 -0.14
CapEx Per Share
0.12 <0.01 0.04 0.06 0.03
Free Cash Flow to Operating Cash Flow
1.53 1.01 1.34 1.34 1.31
Dividend Paid and CapEx Coverage Ratio
-1.89 -59.94 -2.95 -2.94 -3.20
Capital Expenditure Coverage Ratio
-1.89 -59.94 -2.95 -2.94 -3.20
Operating Cash Flow Coverage Ratio
-5.76 -5.81 -0.33 -0.53 -0.28
Operating Cash Flow to Sales Ratio
-12.11 -8.95 -3.84 -15.05 -14.28
Free Cash Flow Yield
-15.92%-5.06%-4.39%-6.12%-3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.98 -16.63 -13.20 -18.08 -16.08
Price-to-Sales (P/S) Ratio
119.68 179.27 117.12 329.53 525.13
Price-to-Book (P/B) Ratio
3.69 6.13 72.61 14.47 65.61
Price-to-Free Cash Flow (P/FCF) Ratio
-6.47 -19.76 -22.76 -16.34 -28.02
Price-to-Operating Cash Flow Ratio
-9.09 -20.02 -30.48 -21.90 -36.76
Price-to-Earnings Growth (PEG) Ratio
0.46 3.48 -0.35 1.64 -0.08
Price-to-Fair Value
3.69 6.13 72.61 14.47 65.61
Enterprise Value Multiple
-6.29 -14.82 -30.27 -23.80 -34.58
Enterprise Value
22.62M 43.54M 33.62M 28.29M 25.17M
EV to EBITDA
-6.08 -14.82 -30.27 -23.80 -34.58
EV to Sales
102.73 149.85 124.37 336.08 560.37
EV to Free Cash Flow
-5.55 -16.52 -24.17 -16.67 -29.90
EV to Operating Cash Flow
-8.48 -16.74 -32.36 -22.34 -39.23
Tangible Book Value Per Share
0.57 1.06 0.05 0.27 0.06
Shareholders’ Equity Per Share
0.57 0.80 0.06 0.28 0.06
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 0.03 -0.06
Revenue Per Share
0.02 0.03 0.03 0.01 <0.01
Net Income Per Share
-0.26 -0.29 -0.30 -0.22 -0.25
Tax Burden
1.00 1.00 1.03 1.00 1.00
Interest Burden
0.77 1.04 0.80 0.90 0.85
Research & Development to Revenue
9.06 4.15 4.18 9.58 17.46
SG&A to Revenue
5.08 1.18 1.64 5.15 2.50
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.88 0.83 0.45 0.83 0.44
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis